Categories: EHRHealthcareNews

Akoya to Report Fourth Quarter and Full Year 2022 Financial Results on March 6th, 2023 and Participate at Two Upcoming Investor Conferences

MARLBOROUGH, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the fourth quarter and full year of 2022 after the market close on Monday, March 6th, 2023. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.

Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

Akoya also announced that Brian McKelligon, CEO, will be participating in two upcoming investor conferences.

  • BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
  • 43rd Annual Cowen Healthcare Conference
    Tuesday, March 7th at 2:10 p.m. ET

A live webcast of the 43rd Annual Cowen Healthcare Conference will be available on the “Investors” section of the Akoya website https://investors.akoyabio.com/.

About Akoya Biosciences

As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
investors@akoyabio.com

Media Contact:
Christine Quern
(617) 650-8497
media@akoyabio.com

Staff

Recent Posts

Brian A. Kessler, DO, DHA, FACOFP dist., Named 2024-2025 President of the American College of Osteopathic Family Physicians

CHICAGO, IL / ACCESSWIRE / April 4, 2024 / The American College of Osteopathic Family…

8 hours ago

Results of the Combined General Meeting on April 2, 2024

All resolutions presented by the Company have been adoptedPARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE…

8 hours ago

Intuitive Health Expands Innovative Healthcare Model in New Mexico with New PRESNow 24/7 Urgent and Emergency Care Location

Intuitive Health Opens 31st Location, Fourth with Presbyterian Healthcare ServicesPLANO, TX / ACCESSWIRE / April…

8 hours ago

Overlake Implements AI Tool to Enhance Patient-Provider Interaction, Improve Productivity

BELLEVUE, WAS / ACCESSWIRE / April 4, 2024 / Overlake Medical Center & Clinics has…

8 hours ago